Eli Lilly and Company (LLY) Q1 2026 Earnings Call Transcript
Eli Lilly and Company reported its first-quarter 2026 earnings on April 30, 2026, exceeding expectations with strong revenue growth and earnings per share. The company highlighted performance across its key therapeutic areas and global operations during the earnings call. Executives discussed financial results, product development progress, and commercial strategies moving forward.
- ▪Eli Lilly reported Q1 2026 earnings per share of $8.55, surpassing estimates by $1.76.
- ▪The company achieved revenue of $19.80 billion, representing a 55.55% year-over-year increase and beating forecasts by $1.99 billion.
- ▪David Ricks served as Chairman and CEO of Eli Lilly during the earnings call.
- ▪The earnings call took place on April 30, 2026, at 10:00 AM EDT.
- ▪Key executives including Lucas Montarce, Daniel Skovronsky, and Patrik Jonsson participated in the call.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4896781-eli-lilly-and-company-lly-q1-2026-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
